4-[(3R)-3-[(3,5-difluoro-2-pyridinyl)methylamino]pyrrolidin-1-yl]-5,6-dimethylpyrimidine-2-carboxamide
C17H20F2N6O — CID 146112391
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[(3R)-3-[(3,5-difluoro-2-pyridinyl)methylamino]pyrrolidin-1-yl]-5,6-dimethylpyrimidine-2-carboxamide
4-[(3R)-3-[(3,5-difluoro-2-pyridinyl)methylamino]pyrrolidin-1-yl]-5,6-dimethylpyrimidine-2-carboxamide (PubChem CID 146112391) has the molecular formula C17H20F2N6O and a molecular weight of 362.38 g/mol. Its IUPAC name is 4-[(3R)-3-[(3,5-difluoro-2-pyridinyl)methylamino]pyrrolidin-1-yl]-5,6-dimethylpyrimidine-2-carboxamide.
Molecular Properties
| Compound Name | 4-[(3R)-3-[(3,5-difluoro-2-pyridinyl)methylamino]pyrrolidin-1-yl]-5,6-dimethylpyrimidine-2-carboxamide |
|---|---|
| PubChem CID | 146112391 |
| Molecular Formula | C17H20F2N6O |
| Molecular Weight | 362.38 g/mol |
| Exact Mass | 362.17 |
| IUPAC Name | 4-[(3R)-3-[(3,5-difluoro-2-pyridinyl)methylamino]pyrrolidin-1-yl]-5,6-dimethylpyrimidine-2-carboxamide |
| SMILES | Cc1nc(C(N)=O)nc(N2CC[C@@H](NCc3ncc(F)cc3F)C2)c1C |
| InChI | InChI=1S/C17H20F2N6O/c1-9-10(2)23-16(15(20)26)24-17(9)25-4-3-12(8-25)21-7-14-13(19)5-11(18)6-22-14/h5-6,12,21H,3-4,7-8H2,1-2H3,(H2,20,26)/t12-/m1/s1 |
| InChIKey | GCOOVVWNSIJCMK-GFCCVEGCSA-N |
| XLogP | 1.23 |
| TPSA | 97.03 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 362.38 |
| LogP ≤ 5 | 1.23 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146112391 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.